Mutations in NRXN1 in a family multiply affected with brain disorders: NRXN1 mutations and brain disorders§

Authors


  • How to Cite this Article: Duong L, Klitten LL, Møller RS, Ingason A, Jakobsen KD, Skjødt C, Didriksen M, Hjalgrim H, Werge T, Tommerup N. 2012. Mutations in NRXN1 in a Family Multiply Affected With Brain Disorders: NRXN1 Mutations and Brain Disorders. Am J Med Genet Part B 159B:354–358.

  • Linh Duong and Laura L. Klitten as well as Niels Tommerup and Thomas Werge, respectively, have contributed equally to this work.

  • §

    Conflicts of interest: Dr. Duong has received a travelling grant by AstraZeneca. Dr. Werge has served as a lecturer for and consultant to H. Lundbeck A/S. Dr. Jakobsen has served on advisory board for Bristol Meyer Squibb, Denmark.

Abstract

Mutation of the neurexin1-gene, NRXN1, interrupting the expression of neurexin1 has been associated with schizophrenia, autism, and intellectual disability. We have identified a family multiply affected with psychiatric, neurological, and somatic disorders along with an intricate co-segregation of NRXN1 mutations. The proband suffered from autism, mental retardation, and epilepsy and on genotyping it was revealed that he carried a compound heterozygous mutation in the NRXN1 consisting of a 451 kb deletion, affecting the promoter and first introns in addition to a point mutation, predicted to be deleterious to NRXN1. The deletion was passed on from the patient's mother who was clinically characterized by sub-diagnostic autistic traits in addition to type 1 diabetes mellitus. The point mutation was subsequently found in the patient's brother, suffering from a psychotic disorder, which implies that the point mutation was inherited from the deceased father, who was diagnosed with schizophrenia. The observations suggest a possible gene-dose effect of NRXN1 mutations on type and severity of mental illness and support the notion that the penetrance and pleiotropy of pathogenic CNVs in general are determined by additional genetic variants in the genome. Finally the findings also propose a linkage of NRXN1 neurobiology to epilepsy and possibly to type 1 diabetes. © 2012 Wiley Periodicals, Inc.

Ancillary